Reply: Re: Yildiz BP, Bayraktaroglu M, Gunen H. Bronchodilator efficacy of tiotropium/formoterol (18/12 μg once daily via a discair inhaler), tiotropium alone (18 μg by handihaler) or combined with formoterol (12 μg twice daily by aerolizer) in adults with moderate-to-severe stable COPD. Curr Med Res Opin. 2019;35(12):2187-2196

Curr Med Res Opin. 2020 Jun;36(6):1061-1062. doi: 10.1080/03007995.2020.1754187. Epub 2020 Apr 29.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adult
  • Bronchodilator Agents* / therapeutic use
  • Formoterol Fumarate / therapeutic use
  • Humans
  • Nebulizers and Vaporizers
  • Pulmonary Disease, Chronic Obstructive* / drug therapy
  • Scopolamine Derivatives / therapeutic use
  • Tiotropium Bromide / therapeutic use

Substances

  • Bronchodilator Agents
  • Scopolamine Derivatives
  • Formoterol Fumarate
  • Tiotropium Bromide